Oxidative stress markers and phosphorus magnetic resonance spectroscopy in a patient with GLUT1 deficiency treated with modified Atkins diet

Brain and Development

Volumn 34, Issue 5, 2012, Pages 372-375

  Kitamura, Yuri ^a   Okumura, Akihisa ^a   Hayashi, Masaharu ^b   Mori, Harushi ^c   Takahashi, Satoru ^d   Yanagihara, Keiko ^e   Miyata, Rie ^b   Tanuma, Naoyuki ^b   Mimaki, Takashi ^c   Abe, Shinpei ^a   Shimizu, Toshiaki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

^e RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

Glucose transporter type 1 deficiency syndrome; Modified Atkins diet; Oxidative stress; Phosphorus magnetic resonance spectroscopy

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEXANOYL LYSINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ATKINS DIET; CASE REPORT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CHILD; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER 1 DEFICIENCY; HUMAN; INBORN ERROR OF METABOLISM; OXIDATIVE STRESS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRESCHOOL CHILD; TREATMENT DURATION;

BIOLOGICAL MARKERS; BRAIN; CARBOHYDRATE METABOLISM, INBORN ERRORS; CHILD, PRESCHOOL; DIET, CARBOHYDRATE-RESTRICTED; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS;

EID: 84859919823     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.08.005     Document Type: Article

References (14)

1. Seidner G., Alvarez M.G., Yeh J.I., O'Driscoll K.R., Klepper J., Stump T.S., et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 1998, 18:188-191.
2. Wang D., Pascual J.M., Yang H., Engelstad K., Jhung S., Sun R.P., et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 2005, 57:111-118.
3. Klepper J. Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia 2008, 49:46-49.
4. Ito S., Oguni H., Ito Y., Ishigaki K., Ohinata J., Osawa M. Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome. Brain Dev 2008, 30:226-228.
5. Hayashi M. Oxidative stress in developmental brain disorders. Neuropathology 2009, 29:1-8.
6. Tanuma N., Miyata R., Kumada S., Kubota M., Takanashi J., Okumura A., et al. The axonal damage marker tau protein in the cerebrospinal fluid is increased in patients with acute encephalopathy with biphasic seizures and late reduced diffusion. Brain Dev 2010, 32:435-439.
7. Du F., Zhu X.H., Qiao H., Zhang X., Chen W. Efficient in vivo 31P magnetization transfer approach for noninvasively determining multiple kinetic parameters and metabolic fluxes of ATP metabolism in the human brain. Magn Reson Med 2006, 57:103-114.
8. Hayashi M., Arai N., Satoh J., Suzuki H., Katayama K., Tamagawa K., et al. Neurodegenerative mechanisms in subacute sclerosing panencephalitis. J Child Neurol 2002, 17:725-730.
9. Hayashi M., Araki S., Arai N., Kumada S., Itoh M., Tamagawa K., et al. Oxidative stress and disturbed glutamate transport in spinal muscular atrophy. Brain Dev 2002, 24:770-775.
10. Hayashi M., Tanuma N., Miyata R. The involvement of oxidative stress in epilepsy. Handbook of free radicals: formation, types and effects 2010, 305-318. Nova Science Publishers, New York. D. Kozyrev, V. Slutsky (Eds.).
11. Chaumeil M.M., Valette J., Guillermier M., Brouillet E., Boumezbeur F., Herard A.S., et al. Multimodal neuroimaging provides a highly consistent picture of energy metabolism, validating 31P MRS for measuring brain ATP synthesis. Proc Natl Acad Sci USA 2009, 106:3988-3993.
12. Rolfe D.F., Brown G.C. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997, 77:731-758.
13. Cox D.W.G., Morris P.G., Feeney J., Bachelard H.S. 31P-n.m.r.studies on cerebral energy metabolism under conditions of hypoglycaemia and hypoxia in vitro. Biochem J 1983, 212:365-370.
14. Saks V.A., Ventura-Clapier R., Aliev M.K. Metabolic control and metabolic capacity: two aspects of creatine kinase functioning in the cells. Biochim Biophys Acta 1996, 1274:81-88.